Login / Signup

Matrix therapy is a cost-effective solution to reduce amputation risk and improve quality of life: pilot and case studies.

Pascal DesgrangesTaina LouissaintBertrand GodeauDenis Barritault
Published in: Regenerative medicine research (2019)
OTR4120 is an effective therapeutic option for patients with chronic lower extremity ulcers, can provide major improvement of quality of life and has the added benefit of being a significant cost-effective solution for healthcare systems.
Keyphrases
  • healthcare
  • lower limb
  • solid state
  • study protocol
  • randomized controlled trial
  • stem cells
  • peripheral artery disease
  • clinical trial
  • mesenchymal stem cells
  • health insurance